Followers | 62 |
Posts | 9562 |
Boards Moderated | 0 |
Alias Born | 03/29/2015 |
Thursday, February 29, 2024 2:47:31 PM
Those of us shareholders who are realistic can just continue to buy more NWBO in good confidence and average down.
We know that even if the SP gets no help from Bethesda and only say doubles or triples on MHRA approval, that puts a lot of us permanently in the green and creates a big profit on those new shares we bought while on the clock for approval. With the way things might drag out, by the time the price hits a very high point where we are willing to sell, the new shares might be taxable as long term gains too.
Not everyone has learned the hard way to stop expecting anything to be soon, let alone have the impact on the SP it should.
The discovery that there are magically newly discovered ‘sub-steps’ to the MHRA process including the potential for ‘off clock’ time is doubtless frustrating to those of us who insist on believing that at some point all that waiting up front should finally buy them a shorter wait on the back end. In a just world it would but if we lived in a just world there would be no GBM and NWBO would not need to exist.
Their frustration can’t be taken out on NWBO or MHRA (not good for their version of the investing thesis) so they take it out on those who point out that with NWBO there are no short cuts.
We will make good money as shareholders in NWBO in 2024 and large numbers of patients will start benefitting in 2025. It will not happen ‘soon’ though.
I remain a buyer as I was in 2023. Others can do what they like, as always. There really isn’t much to say until real news.
Recent NWBO News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM